Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomach Neoplasms 4Carcinoma, Hepatocellular 3Pancreatic Neoplasms 2Uterine Cervical Neoplasms 1Turcot syndrome 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Rectal Neoplasms 1Pancreatic Cancer Resectable 1Pancreatic Cancer Metastatic 1Neoplasms 1Multiple Primary Lung Cancer 1Metastatic Gastroesophageal Junction Adenocarcinoma 1Melanoma 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Cervical Carcinoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Advanced Solid Tumours 1Advanced Solid Tumor 1Advanced Intrahepatic Cholangiocarcinoma 1Advanced Biliary Tract Cancer 1Adenocarcinoma 1

Interventions

sintilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Multiple Primary Lung Cancer × sintilimab × Clear all
NCT04840758 2021-04-12

Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer

The First Affiliated Hospital of Xiamen University

Phase 1/2 Unknown
39 enrolled
Thoracic

Multiple Primary Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡